🧵 5. Novo Nordisk's strategy garners investor appreciation as obesity drug market is projected to hit $100 billion in annual sales. Eli Lilly also set to enter with its drug Mounja.
You are viewing a single comment's thread from:
🧵 5. Novo Nordisk's strategy garners investor appreciation as obesity drug market is projected to hit $100 billion in annual sales. Eli Lilly also set to enter with its drug Mounja.